Furthermore, three patients carrying homozygous compound heterozygous CYP27A1 mutations causing CTX exhibited clinical symptoms such as ataxia, cataract, muscle atrophy, peripheral neuropathy, epilepsy, and pescavu. Here, CYP27A1 is linked to peripheral neuropathy.